1. Home
  2. IMNM vs TENB Comparison

IMNM vs TENB Comparison

Compare IMNM & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$20.57

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Tenable Holdings Inc.

TENB

Tenable Holdings Inc.

HOLD

Current Price

$20.40

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNM
TENB
Founded
2006
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.3B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
IMNM
TENB
Price
$20.57
$20.40
Analyst Decision
Strong Buy
Buy
Analyst Count
10
20
Target Price
$32.80
$34.32
AVG Volume (30 Days)
906.1K
2.5M
Earning Date
03-03-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
51.40
3.23
EPS
N/A
N/A
Revenue
$6,941,000.00
$999,405,000.00
Revenue This Year
$18.41
$9.37
Revenue Next Year
$863.23
$7.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.04
52 Week Low
$5.15
$17.28
52 Week High
$27.65
$37.14

Technical Indicators

Market Signals
Indicator
IMNM
TENB
Relative Strength Index (RSI) 41.75 46.74
Support Level $18.98 $19.15
Resistance Level $22.57 $21.29
Average True Range (ATR) 1.10 0.91
MACD -0.07 0.11
Stochastic Oscillator 25.75 68.07

Price Performance

Historical Comparison
IMNM
TENB

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About TENB Tenable Holdings Inc.

Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.

Share on Social Networks: